The waveLINE-010 trial will compare zilovertamab vedotin ... we look forward to evaluating the potential clinical benefits of a combination regimen with zilovertamab vedotin in patients with diffuse ...
Guardant Health is overcoming skepticism with new cancer tests. Learn why GH stock is a buy, with strong growth and a shift ...
BACKGROUND: The optimal coronary stenting technique for true left main bifurcation lesions is uncertain. EBC MAIN (European ...
Biohaven boasts a robust pipeline with late-stage molecules, but a Hold rating reflects its high market cap and uncertain ...
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good ...
The manuscript addresses the 3D chromatin architecture in monocytes from patients with alcohol-associated hepatitis and its relationship to enhanced transcription of innate immune genes. While the ...
Operator Good day, ladies and gentlemen, and welcome to the Exelixis fourth quarter and fiscal year 2024 financial results ...
Correspondence to Dr Thomas Bandholm, Dept of Clinical Research ... They will look at your trial registration and protocol, if publicly available or submitted with the trial report—comparing the ...
During a Case-Based Roundtable® event, Nitin Jain, MD, and participants discussed treating a patient with CLL after ...
Large language models (LLMs) are poised to have a disruptive impact on health care. Numerous studies have demonstrated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback